| Exercise Intervention Study for Pancreatic Cancer Patients (NCT01977066) | German Cancer Research Center | 2013-11-01 |
| Randomized Phase II Trial of Pre-Operative Gemcitabine and Nab Paclitacel With or With Out Hydroxychloroquine (NCT01978184) | Nathan Bahary, MD | 2013-11-01 |
| Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer (NCT02050178) | OncoMed Pharmaceuticals, Inc. | 2013-11-01 |
| Integrated Cancer Repository for Cancer Research (NCT02012699) | University of Nebraska | 2013-11-01 |
| Veliparib in Combination With Gemcitabine and Intensity Modulated Radiation Therapy in Patients With Pancreatic Cancer (NCT01908478) | Cedars-Sinai Medical Center | 2013-10-02 |
| Comparison Between the 19 and 22 Gauge Needles for Core Tissue Procurement During EUS-guided Procedures (NCT02366858) | AdventHealth | 2013-10-01 |
| Early Detection of Anastomotic Leakage by Microdialysis Catheters (NCT03627559) | Oslo University Hospital | 2013-10-01 |
| Preoperative Nutritional Support in Malnutritional Cancer Patients (NCT02626195) | National Cancer Center, Korea | 2013-10-01 |
| A Prospective, Open Phase I Study to Investigate the Tolerability and Efficacy of ALECSAT to Pancreas Cancer Patients (NCT01984658) | CytoVac A/S | 2013-10-01 |
| OXIRI [Oxaliplatin (O), Xeloda (X) and Irinotecan (I)] in Pancreatic Adenocarcinoma (NCT02368860) | National Cancer Centre, Singapore | 2013-09-17 |
| A Study of Vantictumab (OMP-18R5) in Combination With Nab-Paclitaxel and Gemcitabine in Previously Untreated Stage IV Pancreatic Cancer (NCT02005315) | OncoMed Pharmaceuticals, Inc. | 2013-09-01 |
| Phase II Trial Of Gemcitabine Plus Nab-Paclitaxel +/- OGX-427 In Patients With Metastatic Pancreatic Cancer (NCT01844817) | SCRI Development Innovations, LLC | 2013-09-01 |
| Clinical Registry of nCLE in Masses and Cystic Tumors of the Pancreas, Lymph Nodes, Submucosal Lesions of the GI Tract (NCT01770405) | Mauna Kea Technologies | 2013-09-01 |
| PANFIRE Study: Irreversible Electroporation (IRE) to Treat Locally Advanced Pancreatic Carcinoma (NCT01939665) | Amsterdam UMC, location VUmc | 2013-09-01 |
| An Open-Label Study of a Novel JAK-inhibitor, INCB047986, Given in Patients With Advanced Malignancies (NCT01929941) | Incyte Corporation | 2013-09-01 |
| Phase I Study to evaluate124I-A11 PSCA Minibody in Patients With Metastatic Prostate, Bladder and Pancreatic Cancer (NCT02092948) | Jonsson Comprehensive Cancer Center | 2013-08-22 |
| Radiation w/FOLFIRINOX-Losartan for Pancreatic Cancer (NCT01821729) | Massachusetts General Hospital | 2013-08-16 |
| Phase 3 Study of FOLFIRINOX (mFFX) +/- SBRT in Locally Advanced Pancreatic Cancer (NCT01926197) | Stanford University | 2013-08-14 |
| A Study of Chemoradiotherapy Using Gem Plus Nab-paclitaxel for Pancreatic Cancer (NCT02272738) | Osaka Medical Center for Cancer and Cardiovascular Diseases | 2013-08-01 |
| SII And PALBI is Associated With the Prognosis of Pancreatic Cancer Surgery(SII,PALBI) (NCT05012540) | The Affiliated Hospital of Qingdao University | 2013-08-01 |
| Evaluation of Injection Techniques in Celiac Plexus Neurolysis (NCT02068677) | AdventHealth | 2013-08-01 |
| Irreversible Electroporation for Inoperable Hepatic and Pancreatic Malignancy (NCT02822716) | Chinese University of Hong Kong | 2013-07-22 |
| At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions (NCT01931644) | Sanguine Biosciences | 2013-07-01 |
| Comparing Newly Developed PreCore Needle With Conventional Fine Needle in Suspected Unresectable Pancreatic Cancer (NCT01876069) | Samsung Medical Center | 2013-07-01 |
| Gemcitabine and Pulse Dose Erlotinib in Second Line Treatment of Advanced Pancreatic Cancer (NCT02154737) | Tony Reid, M.D., Ph.D. | 2013-07-01 |
| Cone-beam CT Guided Stereotactic Radiation Therapy for Locally Advanced Pancreatic Cancer (NCT01898741) | UMC Utrecht | 2013-07-01 |
| Dose Escalation Study MORAb-066 Targeting Tissue Factor (TF)-Expressing Malignancies Including Breast, Pancreatic, Colorectal, NSCLC (NCT01761240) | Morphotek | 2013-06-19 |
| Study of S-1 Plus DC-CIK for Patients With Unresectable Locally Advanced Pancreatic Cancer (NCT01781520) | Capital Medical University | 2013-06-01 |
| Safety and Efficacy Study of DCVax-Direct in Solid Tumors (NCT01882946) | Northwest Biotherapeutics | 2013-06-01 |
| A Phase II Study of Locally Advanced Pancreatic Cancer (NCT01867892) | National Health Research Institutes, Taiwan | 2013-06-01 |
| Safety Study of Itacitinib (INCB039110) in Combination With Gemcitabine and Nab-Paclitaxel in Subjects With Advanced Solid Tumors (NCT01858883) | Incyte Corporation | 2013-06-01 |
| Immunotherapy Study in Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer (NCT01836432) | NewLink Genetics Corporation | 2013-05-01 |
| A Japanese Phase 1 Trial of TH-302 in Subjects With Solid Tumors and Pancreatic Cancer (NCT01833546) | Merck KGaA, Darmstadt, Germany | 2013-04-18 |
| Pancreatic Carcinoma: Chemoradiation Compared With Chemotherapy Alone After Induction Chemotherapy (NCT01827553) | University of Erlangen-Nürnberg Medical School | 2013-04-04 |
| C11-Erlotinib PET/CT as a Tool for Identification and Characterization of Tumor With High Expression of Epidermal Growth Factor Receptor(EGFR). (NCT01717807) | Hadassah Medical Organization | 2013-04-01 |
| Study of Lurbinectedin (PM01183) in Combination With Capecitabine in Patients With Metastatic Breast Cancer (MBC), Pancreatic Cancer (PC) or Metastatic Colorectal Cancer (CRC). (NCT02210364) | PharmaMar | 2013-04-01 |
| An Open-Label Study of Ruxolitinib Given With Chemotherapy in Patients With Advanced Solid Tumors (NCT01822756) | Incyte Corporation | 2013-04-01 |
| Etomidate vs. Midazolam for Sedation During ERCP (NCT02027311) | Cheju Halla General Hospital | 2013-04-01 |
| Postoperative Oral Nutritional Supplementation After Major Gastrointestinal Surgery (NCT01838109) | Seoul National University Hospital | 2013-04-01 |
| Functional Magnetic Resonance Imaging of Pancreatic Cancer: a Feasibility and Reproducibility Study (NCT01995240) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2013-04-01 |
| Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Chemotherapy in Participants With Advanced Solid Tumors (NCT01803282) | Gilead Sciences | 2013-03-29 |
| A Study of LY2090314 and Chemotherapy in Participants With Metastatic Pancreatic Cancer (NCT01632306) | Eli Lilly and Company | 2013-03-01 |
| Margin Status After Pancreaticoduodenectomy for Cancer (NCT03267966) | Campus Bio-Medico University | 2013-03-01 |
| Study of Induction Chemotherapy Followed by Radiochemotherapy in Locally Advanced Pancreatic Cancer (NCT02984501) | Campus Bio-Medico University | 2013-03-01 |
| Genetic Evaluation of Families With Endocrine Cancers (NCT01794676) | Jersey Shore University Medical Center | 2013-03-01 |
| Preoperative Oral Immunonutrition for Patients With Pancreatic Cancer Undergoing Elective Surgery - Effect on Complications and Length of Hospital Stay (NCT01789073) | University of Copenhagen | 2013-02-01 |
| Quality of Life After Radiofrequency Ablation of Pancreatic Cancer (NCT02637596) | Brno University Hospital | 2013-02-01 |
| GTX-RT in Borderline Resectable Pancreatic Cancer (NCT01754623) | H. Lee Moffitt Cancer Center and Research Institute | 2013-02-01 |
| Radiofrequency Probe for Management of Unresectable Bile Duct and Pancreatic Cancer (NCT02042859) | Ochsner Health System | 2013-02-01 |
| Trial Comparing 19 and 25G Needles for Fine Needle Aspiration (FNA) of Solid Pancreatic Mass Lesions Greater Than 35mm (NCT01815606) | AdventHealth | 2013-02-01 |
| Evaluating the Number of Passes Required for Diagnostic Cell Block During EUS-FNA of Solid Pancreatic Mass Lesions (NCT01809028) | AdventHealth | 2013-02-01 |
| Minocycline Study in Pancreatic Cancer Patients (NCT01693523) | M.D. Anderson Cancer Center | 2013-01-28 |
| Chemotherapy Plus Proton-chemotherapy for Locally Advanced Pancreatic Cancer (NCT01683422) | Loma Linda University | 2013-01-02 |
| A Study of Pre-Operative Cyberknife in Patients With Potentially Resectable Pancreas Cancer (NCT02707315) | The Cooper Health System | 2013-01-01 |
| Autologous Natural Killer T Cells Infusion for the Treatment of Cancer (NCT01801852) | Chinese PLA General Hospital | 2013-01-01 |
| Improving Pancreas Radiotherapy Plans Using Respiration-driven Anatomic Deformation: A Pilot Study (NCT02024997) | Cedars-Sinai Medical Center | 2013-01-01 |
| Palliative Stereotactic Radiation for Pancreatic or Periampullary Adenocarcinoma (NCT01781728) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2013-01-01 |
| A Study of Pancreatic Cancer in Xenografts From Liver Metastases (NCT01774643) | University Health Network, Toronto | 2013-01-01 |
| Neoadjuvant S-1 and Concurrent Radiotherapy for Borderline Resectable Pancreatic Cancer (NCT02459652) | Japan Adjuvant Study Group of Pancreatic Cancer | 2012-12-28 |
| Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer (NCT01631552) | Gilead Sciences | 2012-12-17 |
| Molecularly Tailored Therapy for Pancreas Cancer (NCT01888978) | Georgetown University | 2012-12-01 |
| Endoscopic Biliary Radiofrequency Ablation of Malignant Distal Common Bile Duct Strictures (NCT01721174) | Chinese University of Hong Kong | 2012-11-01 |
| A Phase I-II Study of PAXG in Stage III-IV Pancreatic Adenocarcinoma (NCT01730222) | IRCCS San Raffaele | 2012-11-01 |
| A Clinical Research About Using Irreversible Electroporation to Treat Locally Advanced Pancreatic Cancer (NCT02841436) | National Taiwan University Hospital | 2012-11-01 |
| Detection of Cancer-Specific Active Proteases in Blood Via Fluorescence (NCT01707758) | University of Kansas | 2012-10-01 |
| Diagnostic Accuracy of FNA: is Aspiration- Related? (NCT01717196) | The Mediterranean Institute for Transplantation and Advanced Specialized Therapies | 2012-10-01 |
| The Clinical,Radiologic,Pathologic and Molecular Marker Characteristics of Pancreatic Cysts Study (NCT01202136) | Johns Hopkins University | 2012-10-01 |
| Clinical Trial of High-dose Vitamin C for Advanced Pancreatic Cancer (NCT01515046) | Joseph J. Cullen | 2012-09-01 |
| Gemcitabine/Abraxane Chemotherapy and Dose Escalated Radiotherapy for Locally Advanced, Unresectable Pancreatic Cancer (NCT01693276) | Olugbenga Olowokure | 2012-09-01 |
| Gemcitabine and CT-011 for Resected Pancreatic Cancer (NCT01313416) | Augusta University | 2012-09-01 |
| Prospective Trial of EUS-FNA Versus EUS-FNB Using a Novel Core Biopsy Needle (NCT01769248) | Northwestern University | 2012-09-01 |
| Identifying Saliva Markers of Patients With Stomach, Colorectal (Including Pre-cancer Polyp) and Pancreatic Cancers (NCT01675258) | Hadassah Medical Organization | 2012-09-01 |
| Trial Comparing Metal Versus Plastic Stents for Preoperative Biliary Decompression (NCT01675908) | AdventHealth | 2012-08-22 |
| A Study of AGS-1C4D4 in Pancreatic Cancer Subjects Previously Treated in Protocol 2008002 (NCT01608711) | Agensys, Inc. | 2012-08-07 |
| Biomarkers in Plasma Specimens From Patients Treated on Study CALGB-80303 (NCT01664169) | Alliance for Clinical Trials in Oncology | 2012-08-01 |
| Efficacy Of Pregabalin In The Treatment Of Pancreatic Cancer Pain. A Randomized Controlled Double-Blind, Parallel Group Study (NCT01768988) | Parc de Salut Mar | 2012-08-01 |
| Combination Chemotherapy With or Without Ganitumab in Treating Patients With Previously Untreated Metastatic Pancreatic Cancer (NCT01473303) | Alliance for Clinical Trials in Oncology | 2012-08-01 |
| Collecting Solid Tumor Tissue to Identify New Treatments (NCT01658917) | National Cancer Institute (NCI) | 2012-07-24 |
| A Trial of Cabozantinib (XL184) and Gemcitabine in Advanced Pancreatic Cancer (NCT01663272) | University of Michigan Rogel Cancer Center | 2012-07-01 |
| Adjuvant Effect of Chloroquine on Gemcitabine (NCT01777477) | University of Zurich | 2012-07-01 |
| Study of Tranexamic Acid for Reducing Blood Requirement in Patients Undergoing Major Gastro-intestinal Surgery (NCT01655641) | Tribhuvan University Teaching Hospital, Institute Of Medicine. | 2012-07-01 |
| Isolation and Characterization of Cancer Stem Cells Using iFP Technique (NCT01641003) | Rambam Health Care Campus | 2012-07-01 |
| Preoperative Folfirinox, Radiation Therapy for Resectable Adenocarcinoma of the Pancreas (NCT01560949) | M.D. Anderson Cancer Center | 2012-06-14 |
| Comparison of Secretin-enhanced Magnetic Resonance Cholangiopancreatography (S-MRCP) to Endoscopic Pancreatic Function Test (ePFT) in Diagnosing Pancreatic Exocrine Insufficiency (NCT01094600) | Columbia University | 2012-06-01 |
| Mirtazapine Plus Gemcitabine Versus Gemcitabine in Metastasis Pancreatic Cancer (NCT01598584) | Tianjin Medical University Cancer Institute and Hospital | 2012-06-01 |
| Parenteral Nutrition in Patients With Biliopancreatic Mass Lesions (NCT02670265) | University Medicine Greifswald | 2012-06-01 |
| Clinical Evaluation Of Needle-based Confocal Laser Endomicroscopy in The Lymph Nodes Along With Masses and Cystic Tumors of the Pancreas (NCT01563133) | Mauna Kea Technologies | 2012-06-01 |
| Negative Pressure Therapy in Preventing Infection After Surgery in Patients With Colon, Rectal, Pancreatic, or Peritoneal Surface Cancer (NCT01656044) | Wake Forest University Health Sciences | 2012-06-01 |
| CAR T Cell Receptor Immunotherapy Targeting Mesothelin for Patients With Metastatic Cancer (NCT01583686) | National Cancer Institute (NCI) | 2012-05-04 |
| A Phase I Study of Recombinant hGM-CSF Herpes Simplex Virus to Treat Cancer (NCT01935453) | OrienGene Biotechnology Ltd. | 2012-05-01 |
| EGF Ointment for Erlotinib Skin Lesion (NCT01593995) | Dong-A University Hospital | 2012-05-01 |
| In Vivo Assessment of Hypoxia in Gastro-intestinal Cancer Using 18F-HX4-PET: an Optimization and Reproducibility Study (NCT01995084) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2012-05-01 |
| Using Electrical Bioimpedance Assessments to Estimate Perioperative Total Body Water and Postoperative Fluid Need (NCT02200055) | United States Naval Medical Center, Portsmouth | 2012-05-01 |
| FOLFIRINOX + RT for Pancreatic Cancer (NCT01591733) | Massachusetts General Hospital | 2012-05-01 |
| Perceptions of Exceptional Patients in Cancer Care Relating to Their Unusual Survival (NCT02055313) | Meir Medical Center | 2012-05-01 |
| A Pilot Trial of Interpersonal Psychotherapy for the Treatment of Depression in Patients With Prostate, Colorectal, Lung and Pancreatic Cancer (NCT01940237) | New York State Psychiatric Institute | 2012-04-01 |
| Phase II Trial Evaluating OS With Therasphere® + 2nd-Line FOLFOX in Pancreatic Liver Mets (NCT01581307) | H. Lee Moffitt Cancer Center and Research Institute | 2012-04-01 |
| Surgical Outcomes Database For Faculty of Hepatopancreatic Biliary Surgery (NCT01657383) | Wake Forest University Health Sciences | 2012-04-01 |
| An Observational Study of Erlotinib Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer (NCT01782690) | Hoffmann-La Roche | 2012-03-31 |
| Effect of Early Management on PAin and DEpression in Patients With PancreatoBiliary Cancer, EPADE-PB (NCT01589328) | National Cancer Center, Korea | 2012-03-15 |